Risk factors and interventional strategies for BK polyomavirus infection after renal transplantation

Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients

(2011) C. Alméras et al.   Transplant Infectious Disease

BK-Virus and the Impact of Pre-Emptive Immunosuppression Reduction: 5-Year Results

(2010) K. L. Hardinger et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Immunosuppressive agents as risk factors for BK virus nephropathy: an overview and update

(2010) Wana Manitpisitkul et al.   Expert Opinion On Drug Safety

Prospective study of polyomavirus BK replication and nephropathy in renal transplant recipients in China: a single-center analysis of incidence, reduction in immunosuppression and clinical course

(2009) Gang Huang et al.   CLINICAL TRANSPLANTATION

Does Reduction in Immunosuppression in Viremic Patients Prevent BK Virus Nephropathy in De Novo Renal Transplant Recipients? A Prospective Study

(2009) Cyrielle Alméras et al.   TRANSPLANTATION

Use of Leflunomide in the Treatment of Polyomavirus BK-Associated Nephropathy

(2008) Judy K Wu et al.   ANNALS OF PHARMACOTHERAPY

Aggressive Immunosuppression Minimization Reduces Graft Loss Following Diagnosis of BK Virus-Associated Nephropathy: A Comparison of Two Reduction Strategies

(2008) A. S. Weiss et al.   Clinical Journal of the American Society of Nephrology